Oncology Medication Market, Global Outlook and Forecast 2023-2030
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
This report aims to provide a comprehensive presentation of the global market for Oncology Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Medication. This report contains market size and forecasts of Oncology Medication in global, including the following market information:
Global Oncology Medication Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Oncology Medication market was valued at US$ 203160 million in 2022 and is projected to reach US$ 340480 million by 2029, at a CAGR of 7.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
We surveyed the Oncology Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Medication Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Oncology Medication Market Segment Percentages, by Type, 2022 (%)
Chemotherapy Medication
Targeted Therapy Medication
Immunotherapy Medication
Hormonal Therapy Medication
Others
Global Oncology Medication Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Oncology Medication Market Segment Percentages, by Application, 2022 (%)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Global Oncology Medication Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Oncology Medication Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Medication revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncology Medication revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Medication, market overview.
Chapter 2: Global Oncology Medication market size in revenue.
Chapter 3: Detailed analysis of Oncology Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
